ObjectivesPublic Health England aims to improve the nation's health and acknowledges
that unhealthy lifestyles, which include drug use, undermine society's
health and well-being. Recreational drug use has changed to include a range of
substances sold as ‘research chemicals’ but known by users as
‘legal highs’ (legal alternatives to the most popular illicit
recreational drugs), which are of an unknown toxicity to humans and often include
prohibited substances controlled under the Misuse of Drugs Act (1971).
Consequently, the long-term effects on users' health and inconsistent,
often illegal ingredients, mean that this group of drugs presents a serious risk
to public health both now and in the future. Therefore, the aim of this study was
to ascertain what is in legal highs, their legality and safety, while considering
the potential impact, these synthetic substances might be having on public
health.DesignA total of 22 products were purchased from five different internet sites,
18 months after the UK ban on substituted cathinones, like mephedrone, was
introduced in April 2010. Each substance was screened to determine its active
ingredients using accepted analytical techniques.SettingThe research was conducted in Leicestershire but has implications for the
provision of primary and secondary healthcare throughout the UK.ResultsTwo products, both sold as NRG-2 from different internet suppliers, were found to
contain the banned substituted cathinones 4-methylethcathinone (4-MEC) and
4-methylmethcathinone (4-MMC), the latter being present in much
smaller quantities. Although sold as research chemicals and labelled ‘not
for human consumption’, they are thinly disguised ‘legal
highs’, available online in quantities that vary from 1 g to
1 kg.ConclusionsDespite amendments to legislation, prohibited class B substances are still readily
available in large quantities over the internet. The findings suggest that these
prohibited substances are being manufactured or imported into the UK on a large
scale, which has serious implications for public health and clinicians who are ill
equipped to deal with this newly emerging problem.